Actively Recruiting
Study of the Progression of Chronic Cardiovascular Conditions
Led by Prolaio · Updated on 2026-02-19
5000
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
CONDITIONS
Official Title
Study of the Progression of Chronic Cardiovascular Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- Ability to understand study assessments and give informed consent to data collection
- Ability to comply with the study protocol
- Ability to understand and respond to instructions in English
- Has diagnosis of qualifying Cardiovascular Disease(s) including but not limited to: heart failure, aortic stenosis, hypertrophic cardiomyopathy, hypertension, dilated cardiomyopathy
- Resides in the United States
You will not qualify if you...
- Allergy to adhesive used in biosensor patch
- Life threatening disease outside of cardiovascular conditions under study, such as actively treated cancer or pre/post-transplant conditions like hepatic failure; end-stage renal disease
- Severe cardiovascular disease defined by hospital admission for cardiac diagnosis within 30 days before enrollment or New York Heart Association functional class IV
- Self-reported weight of 400 pounds or greater
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prolaio
Chicago, Illinois, United States, 60606
Actively Recruiting
Research Team
S
Study Team OCORO Study
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here